mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.02 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.02 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.03 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.03 |
mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.03 |